Recent evidence indicates CGRP as a key factor in the generation of pain in migraine: a study showed that high levels of CGRP can be detected in jugular venous blood during migraine attacks, and it also seems that intravenous injection of CGRP triggers migraine in patients with migraine, but not in healthy volunteers [96,97,98]. Here, CALCA is linked to migraine disorder.